GHP News Global vaccine innovation inAsia-Pacific With 46% of global prophylactic vaccine trials and 31% of therapeutic trials conducted in the Asia-Pacific region, the region has emerged as a global leader in vaccine research and development. A collaborative... 27 November, 20245 min read